1
|
Goldman E: The growth of malignant disease
in man and the lower animals with special reference to the vascular
system. Proc R Soc Med. 1:1–13. 1907.
|
2
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Senger DR, Galli SJ, Dvorak AM, et al:
Tumor cells secrete a vascular permeability factor that promotes
accumulation of ascites fluid. Science. 219:983–985. 1983.
View Article : Google Scholar
|
4
|
Ferrara N: Vascular endothelial growth
factor and the regulation of angiogenesis. Recent Prog Horm Res.
55:15–36. 2000.PubMed/NCBI
|
5
|
Terheyden P, Schrama D, Pedersen LØ, et
al: Longitudinal analysis of MART-1/HLA-A2-reactive T cells over
the course of melanoma progression. Scand J Immunol. 58:566–571.
2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gabrilovich DI and Nagaraj S:
Myeloid-derived suppressor cells as regulators of the immune
system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Rosenberg SO and Sinha P: Myeloid-derived
suppressor cells: Linking inflammation and cancer. J Immunol.
182:4499–4506. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Rubin H: Cancer cachexia: its correlations
and causes. Proc Natl Acad Sci USA. 100:5384–5389. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Deans C and Wigmore SJ: Systemic
inflammation, cachexia and prognosis in patients with cancer. Curr
Opin Clin Nutr Metab Care. 8:265–269. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kajdaniuk D, Marek B, Foltyn W and
Kos-Kudła B: Vascular endothelial growth factor (VEGF) - part 2: in
endocrinology and oncology. Endokrynol Pol. 62:456–464.
2011.PubMed/NCBI
|
11
|
Sanz R, Ovejero VJ, González JJ, et al:
Mortality risk scales in esophagotomy for cancer: their usefulness
in preoperative patient selection. Hepatogastroenterology.
53:869–873. 2006.PubMed/NCBI
|
12
|
Oñate-Ocaña LF, Aiello-Crocifoglio V,
Gallardo-Rincón D, et al: Serum albumin as a significant prognostic
factor for patients with gastric carcinoma. Ann Surg Oncol.
14:381–389. 2007.PubMed/NCBI
|
13
|
Chua W, Charles KA, Baracos VE and Clarke
SJ: Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in
patients with advanced colorectal cancer. Br J Cancer.
104:1288–1295. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cho H, Hur HW, Kim SW, et al:
Pre-treatment neutrophil to lymphocyte ratio is elevated in
epithelial ovarian cancer and predicts survival after treatment.
Cancer Immunol Immunother. 58:15–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Nevala WK, Vachon CM, Leontovich AA, Scott
CG, Thompson MA and Markovic SN: Melanoma Study Group of the Mayo
Clinic Cancer Center: Evidence of systemic Th2-driven chronic
inflammation in patients with metastatic melanoma. Clin Cancer Res.
15:1931–1939. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Coussens LM and Werb Z: Inflammation and
cancer Nature. 420:860–868. 2002.
|
17
|
Shibata M, Shimura T, Gonda K, Suzuki S,
Nakamura I, Ohki S and Takenoshita S: Myeloid-Derived Suppressor
Cells (MDSC) is increased and correlated to immune suppression,
nutritional impairment and inflammatory markers in patients with
gastrointestinal cancer. In: 2012 ASCO Gastrointestinal Cancer
Symposium (Abstract 675); 2012
|
18
|
Ohki S, Shibata M, Gonda K, et al:
Circulating myeloid-derived suppressor cells are increased and
correlate to immune suppression, inflammation and hypoalbuminemia
in patients with cancer. Oncol Rep. 28:453–458. 2012.PubMed/NCBI
|
19
|
Gabrilovich DI, Chen DL, Girgis KR, et al:
Production of vascular endothelial growth factor by human tumors
inhibits the functional maduration of dendritic cells. Nat Med.
2:1096–1103. 1996. View Article : Google Scholar : PubMed/NCBI
|
20
|
Menetrier-Caux C, Montmain G, Dieu MC, et
al: Inhibition of the differentiation of dendritic cells from
CD34(+) progenitors by tumor cells: role of interleukin-6 and
macrophage colony-stimulating factor. Blood. 92:4778–4791.
1998.
|
21
|
Gabrilovich D, Ishida T, Oyama T, et al:
Vascular endothelial growth factor inhibits the development of
dendritic cells and dramatically affects the differentiation of
multiple hematopoietic lineages in vivo. Blood. 92:4150–4166.
1998.
|